5-Amino-1MQ Dosage: How Much to Take, When & How

Overview

5-Amino-1MQ is a small molecule NNMT inhibitor primarily researched for its metabolic effects, particularly fat loss and cellular energy optimization. Unlike traditional peptides, it is a quinolinium salt compound that works by blocking NNMT enzyme activity, which elevates NAD+ levels and shifts cellular metabolism toward increased energy expenditure.

The established oral dosage range is 50–100 mg once daily, making it relatively straightforward to administer. However, optimal dosing varies based on individual goals, experience level, and tolerance. This guide provides detailed protocols for determining the right dose, timing, and cycling approach for your specific situation.

Important Disclaimer: This content is educational and informational only. It is not medical advice, and does not replace consultation with a qualified healthcare provider. 5-Amino-1MQ has limited human safety data and is not approved by regulatory agencies for human use. Always consult a physician before starting any new compound, particularly if you have existing health conditions, are pregnant or breastfeeding, or take medications.

Standard Dosing Protocol

Recommended Dose Range

The evidence-based dosing recommendation is:

• Standard dose: 50–100 mg once daily (oral)
• Frequency: Once per day
• Timing: Consistent daily administration
• Administration: Oral (capsules, powder, or liquid suspension)

This range accommodates most individuals seeking metabolic optimization. The 50 mg lower end suits beginners and those sensitive to new compounds, while 100 mg represents the upper standard dose for established users with good tolerance.

Dose Selection Criteria

Your starting dose should depend on:

1. Prior experience with research compounds
2. Body weight (heavier individuals may tolerate higher doses)
3. Sensitivity to stimulants or metabolic compounds
4. Specific health goals (fat loss vs. general metabolic support)
5. Baseline tolerance to nausea or GI disturbance

Most users begin at the lower end and titrate upward based on tolerance and response.

Dosing by Goal

Fat Loss Protocol

Target dose: 75–100 mg once daily

For fat loss optimization, the higher end of the standard range is most commonly employed. 5-Amino-1MQ's primary evidence base supports fat loss through increased energy expenditure and reduced adipocyte size.

• Dose: 100 mg daily (or 75 mg if GI-sensitive)
• Frequency: Once daily, every morning
• Expected timeline: 8–12 weeks minimum for meaningful assessment
• Combining with diet: Most effective when paired with modest caloric deficit or low-fat dietary approach (as shown in animal models)

Users pursuing fat loss should expect gastrointestinal side effects at higher doses and may need to start at 75 mg before advancing to 100 mg after 1–2 weeks of tolerance assessment.

Metabolic Health & NAD+ Support

Target dose: 50–75 mg once daily

For general metabolic optimization without aggressive fat loss goals, the lower to mid-range dose is appropriate.

• Dose: 50–75 mg daily
• Frequency: Once daily, morning administration preferred
• Timing: With food to reduce GI upset
• Duration: Ongoing, with 4-week assessment intervals

This dosing tier suits individuals focused on mitochondrial support, insulin sensitivity improvement, and cellular energy optimization rather than rapid body composition change.

Cancer Immunotherapy Support (Observational)

Note: Evidence exists only for NNMT inhibition enhancing anti-PD-L1 immunotherapy in bladder cancer contexts. This is not an established human dosing protocol and should only be considered under oncologist supervision.

• Theoretical dose: 50–100 mg daily
• Context: Adjunctive to approved cancer immunotherapy only
• Requirement: Physician oversight and monitoring

Do not use 5-Amino-1MQ as a standalone cancer treatment. Evidence is limited to animal models and observational human studies of NNMT association.

How to Administer

Oral Administration Methods

5-Amino-1MQ is exclusively administered orally. Common delivery formats include:

Capsules

• Typical strength: 25–50 mg per capsule
• Dose adjustment: Take 2–4 capsules to reach target dose
• Timing: Morning, with food or water
• Advantage: Pre-measured, convenient, precise dosing

Powder

• Typical concentration: Varies by supplier
• Dose adjustment: Measure using a scale or provided scoop
• Administration: Mix with water, juice, or add to food
• Advantage: Cost-effective, flexible dosing
• Disadvantage: Requires accurate measurement

Liquid Solution

• Typical concentration: Specified by supplier (often mg/mL)
• Dose adjustment: Use provided dropper or syringe
• Timing: Morning with food
• Advantage: Easy dose titration
• Disadvantage: Taste may be unpleasant for some users

Optimal Administration Timing

• Morning administration: Preferred; aligns with daily energy expenditure peak
• With food: Reduces nausea and GI discomfort; fat or protein-containing meals may improve absorption
• Consistent timing: Take at the same time daily for steady-state levels and habit formation
• Hydration: Drink adequate water throughout the day to support metabolic processes

Storage & Stability

• Temperature: Room temperature (60–80°F); avoid excessive heat
• Light exposure: Store away from direct sunlight
• Moisture: Keep in dry environment; use desiccant packs if supplied
• Shelf life: Typically 2–3 years unopened; check supplier specifications

Cycling & Timing

Standard Dosing Schedule

The current evidence base does not establish a formal cycling protocol for 5-Amino-1MQ. Most practical guidance suggests continuous daily dosing:

• Duration: 8–12 weeks minimum to assess efficacy
• Assessment points: 4 weeks, 8 weeks, 12 weeks
• Ongoing use: Users may continue indefinitely if tolerating well, but periodic breaks (1 week per month) are recommended given the limited human safety data
• Monitoring: Track body weight, energy levels, GI symptoms, and metabolic markers monthly

Suggested Cycling Approach (Precautionary)

Given the theoretical risks of prolonged methylation pathway disruption:

• On-cycle: 12 weeks at target dose
• Off-cycle: 1–2 weeks break
• Repeat: Resume following break; reassess tolerance
• Annual: Take 4–6 weeks completely off compound per year

This cycling approach is not evidence-based but reflects best practices for compounds with limited human safety data.

Seasonal Dosing

Some users adjust dosing based on goals:

• Pre-summer (8–12 weeks): 75–100 mg for accelerated fat loss
• Maintenance (off-season): 50 mg for baseline metabolic support
• Winter: Off-cycle or low-dose maintenance

Adjust based on personal goals and tolerance.

Beginner vs. Advanced Dosing

Beginner Protocol (Weeks 1–4)

Goal: Establish tolerance and assess side effect profile

• Starting dose: 50 mg once daily
• Frequency: Every morning with breakfast
• Duration: 4 weeks at stable dose
• Monitoring: Track energy, appetite, GI symptoms daily
• Adjustment: Only increase if zero adverse effects after 3–4 weeks

Beginner to Intermediate Transition (Weeks 5–8)

• New dose: 75 mg once daily (if tolerated)
• Increase pace: Raise dose by 25 mg increments every 3–4 weeks maximum
• Symptom check: If mild nausea or headache appears, maintain current dose for additional 2 weeks before increasing
• Timeline: Reach target dose by week 8

Advanced Protocol (Weeks 9+)

• Dose: 75–100 mg once daily, or as tolerated
• Optimization: Add dietary modifications (moderate caloric deficit, low-fat shift) if fat loss is goal
• Monitoring: Monthly assessment of weight, energy, metabolic markers
• Cycling: Implement 1-week breaks monthly or follow structured 12-week on/off cycle
• Stacking: Some users combine with other metabolic compounds (under supervision); no formal protocols exist

Common Dosing Mistakes

1. Starting at Maximum Dose

Mistake: Beginning at 100 mg without tolerance assessment.
Result: High risk of GI upset, headache, and early discontinuation.
Solution: Start at 50 mg, titrate slowly over 4–8 weeks.

2. Inconsistent Timing

Mistake: Varying administration time daily.
Result: Suboptimal steady-state levels; difficulty assessing efficacy.
Solution: Set a specific time (e.g., 7 a.m. daily) and stick to it.

3. Taking on Empty Stomach

Mistake: Consuming 5-Amino-1MQ without food.
Result: Increased nausea and GI discomfort.
Solution: Always take with breakfast or substantial food.

4. No Cycling or Breaks

Mistake: Continuous dosing indefinitely without interruption.
Result: Unknown long-term safety profile; potential methylation pathway fatigue.
Solution: Implement monthly 1-week breaks or quarterly cycling.

5. Exceeding 100 mg

Mistake: Attempting doses above 100 mg daily.
Result: Significantly increased side effects; no additional efficacy demonstrated.
Solution: Respect the 50–100 mg range; optimize diet and lifestyle instead.

6. Expecting Overnight Results

Mistake: Assessing efficacy before 4 weeks of consistent use.
Result: False negatives; premature discontinuation.
Solution: Commit to minimum 8–12 weeks at stable dose before evaluating outcomes.

7. Ignoring Side Effects

Mistake: Continuing higher doses despite persistent nausea, fatigue, or headache.
Result: Poor compliance; negative experience.
Solution: If side effects persist after 3 weeks, reduce dose by 25 mg or take week off; consult healthcare provider.

Summary Dosing Table

Conclusion

5-Amino-1MQ dosing is straightforward in principle—50–100 mg once daily, orally—but optimization requires careful titration, consistent timing, and realistic timeline expectations. Beginners should start at 50 mg, increase by 25 mg every 3–4 weeks as tolerated, and avoid exceeding 100 mg daily. Administration with food and consistent morning timing minimize side effects and maximize steady-state levels.

Primary evidence supports fat loss and metabolic optimization; efficacy becomes apparent over 8–12 weeks of consistent dosing. Cycling (12 weeks on, 1–2 weeks off) is recommended given limited long-term human safety data. Always prioritize tolerance assessment before advancing dose, and consult a healthcare provider if you have existing health conditions, take medications, or experience persistent side effects.

With disciplined adherence to these protocols, most users find a sustainable dose that balances efficacy with tolerability at a monthly cost of $40–$90.